PROGRAM SCHEDULE

Use this page to view the abstracts scheduled in the program.

There are two ways to search: you can view each oral or poster session, or you can search for an author's name. Clicking on the Session Reference will expand the view, to show you the abstracts contained in that session. Click on the Abstract Reference Number to view the abstract.

If you are browsing the sessions, you can use the date selection pull-down to select a specific day, or choose Show All to see all sessions.

To search by author name, change the date to Show All unless you wish to limit your search to that author's abstracts on a given day. Enter the author's surname or given name into the name field, and press Search to find all abstracts with an author by that name.

Canadian Neurological Sciences Federation's Congress

SCHEDULE

Date:

Author Name:

Presentation Type:

Word or Phrase:

Showing Records 1 - 25 of 25 [Page: 1 ]

Session#	Date	Time	Room	Session Name
A	Fri, May 24	08:00 - 09:00	MM – BC Room	Platform Presentations, Adult Neurology (CNS)
Moderator: Alex Henri-Bhargava A.1 Repurposing Ambroxol as a disease-modifying treatment for Parkinson’s disease dementia: A phase 2, randomized, double blind placebo-controlled trial A.2 Understanding Grit in healthy older adults at-risk for Alzheimer's disease A.3 Beta-amyloid is a cytokine and Alzheimer's is an autoimmune disease A.4 Neurological events following COVID-19 vaccination: does ethnicity matter? A.5 Investigating myelitis and rheumatologic disease overlap in the era of neuromyelitis optica spectrum disorder and MOG Antibody-associated disease A.6 INDIGO: a global, randomized, double-blinded, Phase 3 study of vorasidenib versus placebo in patients with grade 2 glioma with an IDH1/2 mutation (mIDH1/2) Location: MM – BC Room
B	Fri, May 24	08:00 - 09:00	MM – Alberta Room	Platform Presentations, Canadian Stroke Consortium (CSC)
Moderator: Christian Stapf B.1 CT Or MRI protocol for acute stroke reperfusion with EVT (COMPARE): an international retrospective cohort study B.2 Time from symptom onset and number of health care encounters prior to diagnosis of cerebral venous thrombosis B.3 Neuroimaging markers of cerebrovascular disease and cognition in adults with moderate-great complexity congenital heart disease B.4 Stroke care and neurological emergency response simulation (SCaNERS): high-fidelity acute stroke simulation and its impact on knowledge retention B.5 Video-based prehospital teletriage for acute stroke: primary results from a regional pilot-study B.6 Long-term risk of subsequent stroke after transient ischemic attack or minor stroke: a systematic review and meta-analysis Location: MM – Alberta Room
C	Fri, May 24	08:00 - 09:00	MM – Quebec Room	Platform Presentations, Child Neurology (CACN)
Moderator: Michelle Demos C.1 Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy C.2 An in-depth analysis of pediatric inflammatory myopathies: findings from a comprehensive tertiary care hospital C.3 Retrospective study of sulthiame in treatment of pediatric epilepsy C.4 Neurologic injury in pediatric patients cannulated for rescue extracorporeal life support C.5 Altered inflammatory profiles in critically ill children with neurologic involvement C.6 Sex differences in neurodevelopmental outcomes and brain development from early-life to 8-years in preterm males and females Location: MM – Quebec Room
D	Fri, May 24	08:00 - 09:00	MM – Manitoba Room	Platform Presentations, Clinical Neurophysiology (CSCN)
Moderator: Michelle Mezei D.1 Efficacy, safety, and tolerability of subcutaneous efgartigimod in chronic inflammatory demyelinating polyneuropathy: results from the ADHERE trial D.2 Cost-effectiveness analysis of efgartigimod vs chronic IVIg for treatment of patients with generalized myasthenia gravis in Canada D.3 Interim results for Myasthenia Gravis-resource utilization, epidemiology, survival & treatment patterns (MG-REST) study in Ontario, Canada D.4 Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne muscular dystrophy (EMBARK): Pivotal Phase 3 primary results D.5 Low density scalp electrical source imaging of the ictal onset zone network using source coherence maps D.6 Neurological care and outcomes of pregnant patients with epilepsy in a Canadian tertiary care center (2014-2020) Location: MM – Manitoba Room
E	Fri, May 24	08:00 - 09:00	MM - Algonquin Room	Platform Presentations, Neuroradiology (CSNR)
Moderator: Manohar Shroff E.1 Focal leptomeningeal vascular anomalies on brain MRI: a mimic of leptomeningeal metastatic disease E.2 Proof of concept for liquid biopsy: positive correlation between extracellular vesicles shed by high grade gliomas and volume of hypervascular tumour tissue on MRI E.3 fMRIcorrelates of symptom-specific improvement in STN deep brain stimulation E.4 Machine learning based patient classification to predict neurological deterioration in mild Degenerative Cervical Myelopathy E.5 Designing a paradigm for post endovascular therapy imaging Location:\MM - Algonquin Room
F	Fri, May 24	08:00 - 09:00	MM - NWT Room	Platform Presentations, Neurosurgery (CNSS)
Moderator: Joseph Megyesi F.1 Oscillatory network markers of subcallosal cingulate deep brain stimulation for depression F.2 Comprehensively mapping transcriptionally relevant histone modifications in aggressive meningioma leads to novel biologic insights and therapeutic vulnerabilities F.3 Multicentre prospective validation of integrated molecular classification of meningiomas and prediction of recurrence risk using DNA methylation F.4 Anatomical assessment and comparative analysis of ventricular access points in pterional approach: a cadaveric study F.5 A neurotransmitter-dependent mechanism of ependymal cell activation: Insights into a novel therapeutic target for spinal cord injury F.6 Opportunities for improvement: understanding drivers of emergency department visits within 90 days of posterior spinal decompression surgery Location: MM - NWT Room
GR	Fri, May 24	09:00 - 12:00		Grand Rounds
GR.1 Standardized approach to direct first pass aspiration technique for endovascular thrombectomy: description and initial experience with CANADAPT GR.2 Obesity and multiple sclerosis severity: a Mendelian randomization study GR.3 Distinct longitudinal brain atrophy trajectories in parkinson’s disease clinical subtypes: insight towards precision medicine GR.4 Circadian rhythm influences ischemic core and penumbra volumes in pediatric and young adult populations GR.5 Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS malignancy GR.6 Meningioma molecular classification predicts response to surgery and adjuvant radiotherapy: an integrated clinicomolecular analysis & prospective validation
P01	Tue, May 21	10:45 - 11:45	Poster Station 1	Headache, Dementia, Cognitive Disorders
Moderator: Alby Richard P.004 Real-world effectiveness of intravenous eptinezumab in patients with chronic migraine and previous subcutaneous preventive migraine treatment P.005 Eptinezumab demonstrated efficacy regardless of prior preventive migraine treatment failure: post hoc DELIVER analyses P.006 Barriers and risk factors for emergency room visits vs smartphone app use for migraine in Canada and the United States P.007 Role of neuroimaging in headache management; are we following the guidelines? P.067 Pharmacological prophylaxis for chronic migraine: A systematic review and network meta-analysis of randomized controlled trials P.001 Planning & decision-making in obsessive-compulsive disorder (OCD) through the lens of ERP: a comparative analysis P.002 Distinct neuropsychiatric symptom trajectories in frontotemporal dementia across genetic mutations P.023 Review of imaging changes, cognitive decline, and dementia risk in cancer survivors after chemotherapy Location: Main Mezzanine – Saskatchewan Room
P02	Tue, May 21	10:45 - 11:45	Poster Station 2	Other Adult Neurology
Moderator: Fraser Moore P.008 Spontaneous retropulsion in autopsy verified PSP P.071 Improving care for patients with neurofibromatosis 1 in British Columbia P.051 Parkinson’s disease tremor can show entrainment and distractibility with tapping test P.020 Shifts in daytime functioning items on the insomnia severity scale with lemborexant after 6 months of treatment P.022 Gender disparity in canadian institutes of health research funding within neurology P.024 Sex and gender reporting in clinical trials among neurological US Food and Drug Administration approvals P.065 Understanding treatment barriers and adherence among people living with amyotrophic lateral sclerosis P.066 A 65 year-old male with subacute asymmetric, proximal more than distal upper extremity weakness with associated paresthesias and pain P.021 Nonclinical studies of abuse potential with dual orexin-receptor antagonists: concordance with real-world use P.069 Development of a streamlined multi-disciplinary care pathway for compression neuropathies Location: Main Mezzanine – Nova Scotia Room
P03	Tue, May 21	10:45 - 11:45	Poster Station 3	Stroke
Moderator: Mahesh Kate P.025 Accuracy of code stroke activations: a tale of two comprehensive stroke centres P.026 Success with incrementally faster times to endovascular therapy (SWIFT-EVT): a systematic review and meta-analysis P.027 KNOW BRAIN EMBRACE CARE: A study investigating young adult stroke patients’ knowledge and behaviour around lifestyle P.029 Endovascular therapy for cerebral venous thrombosis: an international survey P.028 Exploring young adult stroke patients’ lived experience, healthy lifestyle habits, and recommendations for designing innovative brain care-related initiatives P.017 Ischemic stroke in young adults: a comparison of outcomes, stroke risk factors and etiologies between males and females P.019 A shared decision-model toolkit for pregnancy related care in neurology Location: Main Mezzanine – New Brunswick Room
P04	Tue, May 21	10:45 - 11:45	Poster Station 4	Other Neurosurgery 1
Moderator: Tejas Sankar P.072 History of the endoscopic approach to the skull base with a highlight on Canada's contributions P.136 Implementation of BC Children’s Hospital’s intraventricular hemorrhage of prematurity management pathway: a quality improvement analysis P.137 Neurosurgical consultations in Nova Scotia: a descriptive analysis P.138 Burnout in Canadian neurosurgery P.139 The use of tranexamic acid in craniotomy: a Canadian survey and literature review P.140 The clinical outcomes of patients with normal pressure hydrocephalus and fecal incontinence P.135 Automated awake brain mapping with eloquentaid: a novel tool for low-resource settings P.142 The use of intraoperative magnetic resonance imaging for endoscopic transnasal transsphenoid surgery in children P.152 In-vivo accuracy of pedicle screws utilizing a supervisory controlled 7DOF robot with OCT guidance Location: Main Mezzanine – Prince Edward Island Room
P05	Tue, May 21	10:45 - 11:45	Poster Station 5	Neuro-oncology 1
Moderator: Joseph Megyesi P.015 Spontaneous regression of acoustic schwannomas: a predictive model P.068 Malignant transformation of a spinal dermoid cyst into carcinosarcoma P.081 Chordoma management with artificial intelligence: a scoping review of current applications and future prospects P.083 Use of jugular venous pressure to optimize outcomes of vestibular schwannoma resection: a review of the literature and proof of concept P.085 Characterizing molecular alterations in glioma growth and progression P.090 Third ventricular pituicytoma: case report and review of the literature P.134 Long-term quality of life deterioration in vestibular schwannoma patients treated with radiotherapy: a matched cohort with surveillance, radiation and surgery P.100 Plasma extracellular vesicle sampling from high grade gliomas demonstrates a small RNA signature indicative of disease and identifies lncRNA RPPH1 as a novel biomarker Location: Conference Floor - Foyer
P06	Tue, May 21	10:45 - 11:45	Poster Station 6	Neuro-oncology 2
Moderator: Dhany Charest P.092 Incidence of tissue-sampled brain metastases pre- and post-COVID-19 in Newfoundland and Labrador: an eight-year review P.087 Factors affecting health-related quality of life among adult meningioma patients: a systematic review P.088 Wounded glioma syndrome: neurologic worsening in patients with subtotal resection in high-grade gliomas P.091 Synthetic data reliably reproduces brain tumor primary research data P.093 BMI as a predictor of recurrence in high-grade meningioma: A single center retrospective cohort study P.094 Incidence of pathologically confirmed primary malignant brain tumours in Newfoundland and Labrador: an eight-year review spanning 2015-2022 P.095 Role of selective neck dissections in the management of carotid body tumours P.099 Transfer RNA fragments in patient plasma extracellular vesicles as biomarkers of high grade glioma Location: Conference Floor – Foyer
P07	Tue, May 21	10:45 - 11:45	Poster Station 7	Neurovascular and Neurointerventional/Functional Neurosurgery and Pain
Moderator: Courtney Casserly P.124 Assessing the fragility index of randomized controlled trials on carotid artery stenosis: systematic review P.122 Left temporal aneurysm resection: surgical approach in Pial-Pial collateral formation from the posterior temporal artery secondary to left internal artery occlusion P.123 Is there an association between geographical location of patients in NS and management of unruptured, incidental intracranial aneurysm? P.125 Cerebral AVM recurrence post gamma knife obliteration: a 20 year single centre retrospective analysis and review of literature P.076 Long-term outcomes of radiofrequency ablation for temporal lobe epilepsy P.078 fMRI-based deep brain stimulation programming: a blinded, crossover clinical trial Location: Conference Floor – Toronto Room
P08	Tue, May 21	10:45 - 11:45	Poster Station 8	Neuroimaging
Moderator: Sunita Venkateswaran P.105 Corpus callosum changes in children affected by infantile hydrocephalus P.107 How often does digital subtraction angiography change management in CT angiogram negative subarachnoid hemorrhages? P.108 Rate and clinical utility of early postoperative CT head in adult craniotomy P.109 Machine learning based approach to improving the prediction of neurological deterioration in mild Degenerative Cervical Myelopathy P.073 Spontaneous fluctuation of contrast enhancement in adult pilocytic astrocytoma and other low-grade brain tumors P.074 Assessing the emergence and evolution of artificial intelligence and machine learning research in neuroradiology P.075 Anatomy and pathology of the lacrimal apparatus: from the sac to the nasal fossa. what the neuroradiologist should know! Location: Conference Floor - Exhibit Hall, but access via Toronto Room
P09	Tue, May 21	10:45 - 11:45	Poster Station 9	Child Neurology 1
Moderator: David Dufresne P.037 Refractory status dystonicus and hypotension after cardiac arrest in a child with AADC deficiency post gene therapy: a case report P.038 Exploring alternative deep brain stimulation targets for movement disorder in children – a systematic literature review P.044 Ambient air pollution and emergency department presentations for pediatric primary headache and seizure disorders in Calgary, Canada P.045 Trofinetide for the treatment of Rett syndrome: long-term safety and efficacy results from the open-label LILAC and LILAC-2 studies P.046 Review of the management of Wernicke encephalopathy in pediatrics P.048 Prevalence, type and risk factors of intracranial hemorrhage in term neonates: a systematic review and meta-analysis Location: Conference Floor - Exhibit Hall, but access via Toronto Room
P10	Thu, May 23	10:45 - 11:45	Poster Station 1	MS / Neuroinflammatory Disease
Moderator: Fraser Moore P.009 Long-term comparative efficacy of inebilizumab from N-MOmentum participants versus azathioprine and immunosuppressants and placebo in NMOSD patients P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD participants with history of immunosuppression treatment prior to N-MOmentum study P.011 Efficacy and safety of ravulizumab in adults with AQP4+ NMOSD: interim analysis from the ongoing phase 3 CHAMPION-NMOSD trial P.012 A global, long-term, prospective, observational registry of patients with AQP4+ NMOSD treated with complement component 5 inhibitor therapies eculizumab or ravulizumab P.013 Accuracy of clinical assessments with virtual care in outpatient neurological setting P.014 Intravenous immunoglobulin use for central nervous system disorders in British Columbia: implementation of a provincial screening program P.052 Utility of amyotrophic lateral sclerosis functional rating scale (ALSFRS) bulbar subscores for predicting need for gastrostomy tube Location: Main Mezzanine – Saskatchewan Room
P11	Thu, May 23	10:45 - 11:45	Poster Station 2	Epilepsy and EEG
Moderator: David Dufresne P.036 Vagal nerve stimulation in three cases of continuous spike and wave in slow-wave sleep P.032 The importance of transition clinics: A chart-review examining demographic, health, and social variables in young adults with epilepsy who were recently transitioned P.033 Electrophysiological signatures of sedation in pediatric patients P.035 Cardiac screening in children with genetic epilepsy at risk for sudden unexpected death in epilepsy P.003 Outcome of psychogenic nonepileptic seizures following diagnosis in the epilepsy monitoring unit P.049 Acetazolamide use for myoclonus: case report of 2 patients with progressive myoclonic epilepsy and literature review P.050 Spike source localizations between the three non-REM sleep stages: resemblances to wakefulness and distinctions from REM sleep Location: Main Mezzanine – Nova Scotia Room
P12	Thu, May 23	10:45 - 11:45	Poster Station 3	Neurotrauma/Neurocritical Care
Moderator: Draga Jichici P.121 Subgaleal versus subdural drain after minicraniotomy for chronic subdural haematoma P.114 The impact of screening for anxious and depressive symptoms on the outcome of patients with a mild traumatic brain injury P.115 The national impact of traumatic brain injury on labor markets: a canada-wide observational cohort study of post-injury employment and personal income loss P.116 Days at home after traumatic brain injury: moving beyond mortality to evaluate patient-centered outcomes using population health data P.119 NIRS regional oxygen saturation based cerebrovascular reactivity in the recovery from moderate/severe TBI P.104 Prognostic value of NIRS regional oxygen saturation based cerebrovascular reactivity in TBI: a Canadian high resolution traumatic brain injury (CAHR-TBI) cohort study P.117 Antiplatelet and anticoagulation use and outcomes following chronic subdural hematoma drainage: systematic review and meta-analysis Location: Main Mezzanine – New Brunswick Room
P13	Thu, May 23	10:45 - 11:45	Poster Station 4	Other Neurosurgery 2
Moderator: Michael Tso P.126 An unlikely impersonator of primary brain tumours: Illustrative case report and literature review of primary angiitis of the central nervous system P.127 Quality of life QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia P.130 Endoscopic fenestration of trapped fourth ventricle P.131 Comparison of interhemispheric and transcortical approaches for resection of colloid cysts of the third ventricle P.132 Blood loss quantification and management strategies in cranial neurosurgery: a systematic review P.133 Neurons in the lateral prefrontal cortex encode task features during virtual navigation P.129 Canadian neurosurgical healthcare spending trends P.079 Relationships between anatomical features and outcome after stereotactic laser amygdalohippocampotomy Location: Main Mezzanine – Prince Edward Island Room
P14	Thu, May 23	10:45 - 11:45	Poster Station 5	Neuro-oncology 3
Moderator: Joseph Megyesi P.086 The effect of after-hours surgical resection on the outcomes in patients with high grade gliomas P.097 Glioblastoma treatment, end-of-life resource utilization, and outcomes in Ontario P.084 Early malignant transformation of intracranial epidermoid cysts: a case report and systematic review P.082 Preoperative corticosteroids reduce diagnostic accuracy for primary central nervous system lymphoma biopsies: a meta-analysis P.089 Volumetric extent of resection and visual outcomes in pituitary adenoma patients presenting with visual compromise undergoing the endoscopic endonasal approach P.096 Hearing preservation and quality of life outcomes in partial labyrinthectomy petrous apicectomy for microsurgical resection of large posterior fossa skullbase tumors P.102 Integration of Ultrasensitive electroluminescent immunoassay and cell-free DNA methylation analysis for the non-invasive discrimination of adult diffuse gliomas P.103 Automated pituitary adenoma segmentation for radiosurgery with deep learning-based model P.106 Using optic nerve sheath diameter over ventricular size to assess elevated intracranial pressure in pediatric patients with pineal region tumors Location: Conference Floor – Foyer
P15	Thu, May 23	10:45 - 11:45	Poster Station 6	Spine and Peripheral Nerve Surgery
Moderator: Gwynedd Pickett P.149 Saskatchewan spine pathway classification is associated with post-operative outcome and improved quality-adjusted life years following lumbosacral fusion P.143 Safety of same-day discharge following incidental durotomy in tubular microdiscectomy: a retrospective cohort study P.144 Comparative analysis of spinal cord-derived and induced pluripotent-derived neural stem & progenitor cells for SCI therapy P.147 The growing problem of spine surgery wait times in British Columbia: longitudinal trends and impacts on perioperative outcomes P.148 Consult and kyphoplasty delay impacts on geriatric vertebral compression fracture outcomes P.150 Effect of postoperative pain control and other perioperative risk factors on length of stay after elective spine surgery P.151 A critical appraisal of the application of frailty and sarcopenia in the spinal oncology population P.153 Utility of neurophysiology in the diagnosis of tethered cord syndrome (TCS) Location: Conference Floor – Foyer
P16	Thu, May 23	10:45 - 11:45	Poster Station 7	Neuroscience Education
Moderator: Steven Ray Peters P.110 Evaluating AI performance in written neurosurgery exams: a comparative analysis of large language models P.111 The surgeon experience of flow P.112 Understanding obstacles: a neurosurgical view on gender disparities in career progression P.113 Mind the gap: illuminating gender disparities in neurosurgical inclusion and diversity P.070 Using AI to revolutionize clinical training through OSCE-GPT: a focused exploration of user feedback on otolaryngology and neurology cases P.016 Re-norming medical education: centering patient experience and diverse bodies in Lumbar Puncture (LP) instruction Location: Conference Floor – Toronto Room
P17	Thu, May 23	10:45 - 11:45	Poster Station 8	Neuromuscular Disease and EMG
Moderator: Steven K. Baker P.054 Long-term safety and efficacy of zilucoplan in myasthenia gravis: additional interim analyses of RAISE-XT P.056 Real-world reduction in oral corticosteroid utilization following efgartigimod initiation in patients with generalized myasthenia gravis P.057 Achievement of minimal symptom expression in acetylcholine receptor antibody-positive participants treated with efgartigimod in ADAPT/ADAPT+ P.060 Provider and patient perspectives on outcome measure use in clinical care for chronic inflammatory neuropathy P.055 Corticosteroid dose tapering in patients with generalised myasthenia gravis on zilucoplan: Interim analysis of RAISE-XT P.058 Neuromuscular neurologists’ experience in recognizing, diagnosing, and treating Long-chain fatty acid disorders (LC-FAOD): a national survey P.062 Normal NCS in 42-year-old man with PMP22 duplication P.064 A case of late onset Pompe Disease presenting in 6th decade P.053 Concomitant corticosteroid use in ravulizumab-treated adults with anti-AChR antibody-positive gMG: results from the CHAMPION MG open-label extension Location: Conference Floor - Exhibit Hall, but access via Toronto Room
P18	Thu, May 23	10:45 - 11:45	Poster Station 9	Child Neurology 2
Moderator: Dakota Peacock P.039 Informing treatment advancement and innovation in a tertiary care neurocritical care (NCC)) program P.040 Decreased incidence of neuro-autoimmune disorders during COVID-19 pandemic restrictions P.041 3 year longitudinal health related quality of life in a spinal muscular atrophy cohort P.042 Anti-HMG Coenzyme A reductase antibody (anti-HMGCR) myopathy: case review of two pediatric patients from a single center P.043 Developing a brief clinical dataset for Duchenne Muscular Dystrophy P.063 Refractory pediatric CIDP converting to full recovery with rituximab P.059 Weill-Marchesani Syndrome – a rare etiology for bilateral carpal tunnel syndrome in children P.047 Survey of caregivers of individuals with NBIAs to identify relevant quality of life outcomes Location: Conference Floor - Exhibit Hall, but access via Toronto Room